Trial shows responses to abiraterone acetate in some prostate cancer patients with initial hormone induction failure
Patients with metastatic prostate cancer whose PSA levels remain high despite initial hormone treatments have historically had poor prognosis, with survival typically in the 1-2 year range. Results of a 40-person clinical ...
Apr 5, 2017
0
1